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Abstract Mesenchymal stem cell differentiation of
osteoblasts is triggered by a series of signaling processes
including integrin and bone morphogenetic protein (BMP),
which therefore act in a cooperative manner. The aim of
this study was to analyze whether these processes can be
remodeled in an artiﬁcial poly-(L)-lactide acid (PLLA)
based nanoﬁber scaffold. Matrices composed of PLLA-
collagen type I or BMP-2 incorporated PLLA-collagen
type I were seeded with human mesenchymal stem cells
(hMSC) and cultivated over a period of 22 days, either
under growth or osteoinductive conditions. During the
course of culture, gene expression of alkaline phosphatase
(ALP), osteocalcin (OC) and collagen I (COL-I) as well as
Smad5 and focal adhesion kinase (FAK), two signal
transduction molecules involved in BMP-2 or integrin
signaling were analyzed. Furthermore, calcium and colla-
gen I deposition, as well as cell densities and proliferation,
were determined using ﬂuorescence microscopy. The
incorporation of BMP-2 into PLLA-collagen type I
nanoﬁbers resulted in a decrease in diameter as well as pore
sizes of the scaffold. Mesenchymal stem cells showed
better adherence and a reduced proliferation on BMP-
containing scaffolds. This was accompanied by an increase
in gene expression of ALP, OC and COL-I. Furthermore
the presence of BMP-2 resulted in an upregulation of FAK,
while collagen had an impact on the gene expression of
Smad5. Therefore these different strategies can be com-
bined in order to enhance the osteoblast differentiation of
hMSC on PLLA based nanoﬁber scaffold. By doing this,
different signal transduction pathways seem to be up
regulated.
1 Introduction
The reconstruction of large bony defects after injury or
tumor resection often requires the use of bone substitution.
In Europe 500,000 surgeries/year require bone graft
material [1]. Therefore artiﬁcial scaffolds based on syn-
thetic biomaterials such as metals, polymers, porous
ceramics, hydroxyl apatite, collagen sponge or hydrogels,
and composites have been developed [2–8].
Among them, scaffolds based on nanoﬁbers or nano-
scaffolds offer great advantages [9, 10]. They are thought
to mimic the extracellular matrix (ECM) [11–14] and allow
the differentiation of human mesenchymal stem cells
(hMSC) towards osteoblasts. However, this process
depends on the chemical composition of the nanoﬁbers.
In comparison to other a-(hydroxyester)-based nanoﬁ-
brous scaffolds, poly-(L)-lactide acid (PLLA) scaffolds
supported the highest rate of proliferation of mesenchymal
stem cells [15] with a tendency to higher cell densities
[16, 17]. However, an initial down regulation of genes
associated with the osteoblast linage [16, 18] can be
observed on PLLA nanoﬁbers. This effect can be elimi-
nated by functionalisation of the nanoﬁbers either by
blending with collagen type I [19] or the incorporation by
recombinant bone morphogenic protein 2 (BMP-2) [16].
Both strategies enhanced the differentiation of mesenchy-
mal stem cells towards osteoblasts. In terms of collagen it
is known that the adhesion to collagen I (COL-I) via the
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ation of hMSC’s, even in the absence of exogenous stimuli
[20, 21]. BMP-2 induces different factors involved in the
differentiation of hMSC towards osteoblasts [22–31] and is
necessary to induce bone formation [32–34]. Furthermore
BMP-2 induces the formation of avb-Integrin on osteo-
blasts [35, 36]. These, in interaction with the ECM, inﬂu-
ences the BMP-function [36] resulting in migration,
activation of focal adherence kinase and formation of focal
adhesion [37, 38]. Suzawa et al. [39] found evidence, that
the downstream pathway of integrin is involved in Smad1
signals activated by BMP-2 and provide a possible mech-
anism for cooperation between intracellular signals acti-
vated by integrin and BMP receptors in osteoblastic cells.
In order to analyze whether this cooperative effect can
be utilized in PLLA nanoﬁber based bone replacement
material we constructed BMP-2 containing PLLA-collagen
type I blended nanoﬁber scaffolds and analyzed their
ability to induce osteoblast differentiation of hMSC.
2 Materials and methods
2.1 Construction of nanoﬁbers and characterization
The preparation of PLLA and PLLA-collagen type I blend
nanoﬁbers as well as the incorporation of BMP-2 into PLLA
nanoﬁbersbyelectrospinninghasbeenreportedindetailearlier
[16, 19, 40]. Brieﬂy, a 4% (w/w) PLLA (Resomer L210,
Boeringer Ingelheim Germany) solution in dichloromethane
(DCM)waspreparedatroomtemperaturebystirringovernight
until a homogenous solution was obtained. Spinning process
was performed at a ﬂow rate of 14 ll/min with an applied
voltage of 20–30 kV and a distance of 15 cm. The spinning
solution had a surface tension of 28.34 ± 0.03 mN/m, a vis-
cosity of 1.561 PaS and a conductivity of *0 ls/cm. Samples
of non woven PLLA nanoﬁbers were ﬁxed on 18 mm cover
slips for cell culture experiments.
To incorporate collagen type I into the nanoﬁbers,
PLLA and collagen were dissolved in hexaﬂuoroisopro-
panol (HFIP) in a 4:1 ratio resulting in a 4.5% (w/v)
polymer solution. Here the spinning solution had a surface
tension of 18.33 ± 0.03 mN/m, a viscosity of 1.529 PaS
and a conductivity of *4.7 ls/cm. Spinning process was
performed at a ﬂow rate of 14 ll/min with an applied
voltage of 10–18 kV and a distance of 15 cm.
In order to incorporate BMP-2 into the nanoﬁbers, 25 lg
lyophilized BMP-2 (Reliatech, Braunschweig Germany) was
dissolved in 125 ll 50 mM acetic acid and stabilized by the
addition of 25 ll fetal calf serum (FCS). This mixture was
emulsiﬁed in 2.5 ml of a 4.5% PLLA-collagen type I solution
(4:1) over a period of 1 min using a vortex mixer (MS 2
Minishaker IKA
; 2,500 rpm). This solution was sufﬁcient for
the spinning of 50 cover slips with BMP-2 depending on the
spinning and ﬁber collection process. Spinning process was
performedataﬂowrateof14 ll/minwithanappliedvoltageof
10–18 kV and a distance of 15 cm. In some experiments BMP
was replaced by a ﬂuoresceinisothiocyanat (FITC)-labeled
protein, to analyze the distribution within the nanoﬁbers and
release of growth factors form the PLLA Collagen ﬁbers.
2.2 Pore size distribution
The pore size distribution of the three electrospun scaffold
wasdeterminedusingacapillaryﬂowporometer(type:CFP-
1200-AEXL,Porous MaterialsInc., USA). Awetting liquid,
Galwick
TM (Porous Materials Inc., USA) was applied to
spontaneously ﬁll the pores in the scaffold and differential
pressure of nitrogen gas was slowly increased on the sample
to remove the liquid within the pores and permit gas ﬂow.
The differential pressure and ﬂow rates through dry and wet
scaffold were measured. All the required pore structure
characteristics such as pore size at bubble point mean ﬂow
pore and pore size distribution were computed from the
measured differential pressures and gas ﬂow rates [41].
2.3 Scanning electron microscopy
For scanning electron microscopy (SEM), samples were
sputter-coated with gold in an AUTO-306 (BOC Edwards,
Crawley, Sussex, U.K.) high-vacuum coating system and
examined in a SEM (S-4100, Hitachi Ltd., Tokyo, Japan) at
an accelerating voltage of 5 kV in the SE mode.
2.4 Human mesenchymal stem cell isolation,
characterization and culture
HMSC cells were obtained from consenting patients with
the approval of the institutional review board. The indi-
cation for surgery was primary osteoarthritis of the hip.
The patients had no evidence of other bone or auto immune
diseases. The routinely removed bone was obtained from
the proximal femur, while preparing the implant bed.
HMSC were isolated and cultured according to the prepa-
ration of Pittenger et al. [42], with minor modiﬁcation as
described by Brendel et al. [43].
Within the experiments, hMSCs preparations negative
for CD34 and CD40 and positive for the stem cell markers
CD90 and CD105 were used. In order to ensure the
osteoinductive potential of the obtained cells, gene
expression of alkaline phosphatase (ALP), in response to
dexamethasone, was determined prior to the experiments.
For experiments, hMSC were seeded at a density of
3 9 10
4 cells/cm
2 on cover slips or cover slips coated with
nanoﬁbers in growth medium (DMEM), with low glucose
and glutamine (PAA, Linz, Austria) supplemented with
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Berlin, Germany) and 1% penicillin/streptomycin. Osteo-
genic differentiation was induced according to Jaiswal
et al. [44] after an initial proliferation phase of 3 days.
The medium was replaced every second day of culture.
2.5 Gene expression analysis
RNA was extracted from cell layers at days 2, 4, 10 and 22
(after introduction of osteoinductive conditions) using
Peq Gold total RNA Kit (PeqLab, Erlangen, Germany)
according to the manufacturer and quantiﬁed spectromet-
rically. Starting from 1 lg RNA, 20 ll cDNA were syn-
thesized using Verso cDNA Kit (Thermo Fisher Scientiﬁc,
Lafayette, USA) with oligo-dT primer in the presence of
dNTP. Quantitative RT–PCR reactions were performed and
monitored using a Mastercycler
 ep realplex Detection
System (Eppendorf, Hamburg, Germany) and Absolute Blue
QPCR Sybr Green Mix (Thermo Fisher Scientiﬁc, Lafay-
ette, USA). Genes of interest were analyzed in cDNA
samples (5 ll for a total volume of 50 ll/reaction) using
DeltaDeltaCt method and CyberGreen. Primers (purchased
at TIB Biomol, Berlin, Germany), cycle temperatures and
incubation times for human alkaline phosphatase (ALP),
collagen I (COL-I), osteocalcin (OC), and 18 s rRNA were
previously described [45–47]. The primer sequence for focal
adhesion kinase (FAK) was 50ACC TCA GCT AGT GAC
GTA TGG -30 and 50CGG AGT CCC AGG ACA CTG TG
30 (gen bank L0518666), PCR Primers for Smad5 were
obtained ready to use form www.realtimeprimers.com.
2.6 Immunoﬂuorescence microscopy
Samples were ﬁxed in acetone/methanol, washed with PBS
(39), and exposed to blocking buffer (1% donkey serum
albumin PBS) over a period of 30 min at room temperature
to minimize non-speciﬁc absorption of the antibodies. After
another wash in PBS (39), the cells were incubated with
primary antibodies against COL-I (Abcam, Ab6308, Cam-
bridge, United Kingdom), OC (Acris, BP710, Hiddenhau-
sen, Germany), Ki-67 (Darko, Hamburg, Germany) FAK
(BD Biosciences, San Jose, California, USA) and Smad5
(Santa Cruz Biotechnology, Inc. Heidelberg, Germany).
Visualization was done, after washing in PBS (39) using
cy-2- or cy-3-conjugated secondary antibody (Dianova,
Hamburg, Germany) at room temperature (1 h). The slices
were stained with DAPI and embedded in mounting med-
ium. Fluorescence microscopy was done using a Leica
DM5000. Microphotographs of at least three different areas
were made and intensity of ﬂuorescence was determined
using Quips analysis software. Total cell count of DAPI
stainednucleiwereobtained.Patientserieswereanalyzedby
independent observers.
2.7 Detection of calcium deposition
Von Kossa staining was performed using 1% aqueous sil-
ver nitrate solution for 1 h followed by several washing
steps in distilled water and incubation in 5% sodium
thiosulfate for 5 min. Alizarin red staining was performed
using 2 g/100 ml at pH 4.1–4.3.
2.8 Statistics
All values were expressed as mean ± standard error of at
least three different patients and compared using student’s
t-test or ANOVA with Bonferroni as a post hoc test. Values
of P\0.05 were considered to be signiﬁcant. Signiﬁcant
values were marked with *.
3 Results
3.1 Characterization of PLLA collagen blend
nanoﬁbers with or without BMP-2 incorporation
Scanning electron microscopy of electrospun PLLA nanof-
ibers revealed a 3-D non-woven network with a diameter of
0.775 ± 0.294 lm. Fibers were porous in structure.
The PLLA-collagen type I blend nanoﬁbers revealed a 3-D
non-woven network with a diameter of 0.421 ± 0.023 lm
for the blend (Fig. 1c). The PLLA-collagen type I blend
nanoﬁbers presented themselves with a relatively smooth
surface(Fig. 1a).Theporesizeoftheresultingscaffoldswas
about 2 lm as demonstrated in Fig. 1d.
The incorporation of BMP-2 into these ﬁbers reduced the
diameter to 0.217 ± 0.009 lm and resulted in a smaller pore
size(approximately0.6 lm)asshowninFig. 1bandc.When
FITC labelled bovine serum albumin (BSA) was used as a
model for the incorporation of proteins by electrospinning,
ﬂuorescence microscopy showed evidence that the dye was
distributed uniformly within the ﬁbers (Fig. 2a). When these
ﬁbers were incubated in phosphate buffer at 37C, the ﬂuo-
rescence remained within the ﬁber over a period of 14 days
(Fig. 2b). Nevertheless the sharpness of the ﬁbers becomes
indistinct. Correspondingly using UV–visible-spectroscopy,
notimedependentreleasecouldbedetected(datanotshown).
3.2 Adhesion of mesenchymal stem cells on nanoﬁber
scaffolds
In order to describe the biological effects of blending
PLLA with collagen as well as the incorporation of BMP-2
into PLLA-collagen type I blend nanoﬁbers, we ﬁrst ana-
lyzed the adhesion of hMSC on the desired scaffolds. Cells
were seeded on the scaffolds and allowed to adhere over a
period of 12 h. As shown in Fig. 3, during this time,
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collagen type I blend nanoﬁbers. Nevertheless, this effect
was not signiﬁcant at all. The incorporation of BMP-2 into
the PLLA-collagen type I blend scaffolds resulted in a four
to ﬁve fold increase (p = 0.044).
3.3 Growth and proliferation of human hMSC cultured
on nanoﬁbers
Focusing on growth of hMSC, we next cultured the cells
over a period of 22 days on PLLA, PLLA-collagen type I,
and PLLA-collagen type I nanoﬁber scaffolds containing
BMP-2. Under growth conditions signiﬁcant differences
between cell densities between PLLA and PLLA-collagen
type I (p = 0.000) as well as PLLA-collagen type I con-
taining BMP-2 (p = 0.015) were found after 22 days
(Fig. 4a).
Under osteoinductive conditions after 4 days of culture
signiﬁcance was reached (PLLA/PLLA-collagen nanoﬁ-
bers P = 0.001; PLLA-collagen nanoﬁbers containing
BMP-2 (p = 0.000)). In case of PLLA-collagen nanoﬁbers
signiﬁcant higher cell densities were found over the time
Fig. 1 Fiber characterization. SEM analysis of PLLA-collagen blend (a) and BMP-2 enwoved PLLA-collagen blend nanoﬁbers (b) and the
resulting ﬁber diameters (c) and pore sizes of the PLLA-collagen blend (d) and BMP-2 enwoved PLLA-collagen blend nanoﬁbers (e)
Fig. 2 Release characteristics of BMP-2 enwoved PLLA-collagen blend nanoﬁbers. Fluorescence microscopy analysis of BMP-2 enwoved
PLLA-collagen blend nanoﬁbers after incubation in aquarius solutions over a period of 1 (a) and 14 days (b)
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(day 10, P = 0.004; day 22, P = 0.003). At these time
points no signiﬁcant differences between PLLA and PLLA-
collagen type I nanoﬁbers containing BMP-2 were detected
(Fig. 4b). This growth pattern was reﬂected in the gene
expression of Cyclin 1D (CCND) normalized to 18 s. Here
the gene expression was increased when cells were cul-
tured on PLLA-collagen type I blend nanoﬁbers as com-
pared to PLLA nanoﬁbers. Furthermore the presence of
BMP-2 resulted in a reduced CCND gene expression
(Fig. 4f). Consequently this pattern could be detected using
Ki67 staining (Fig. 4c, d, e).
Fig. 3 Inﬂuence of PLLA, PLLA-collagen blend and BMP-2
containing PLLA-collagen blend nanoﬁbers on adhesion
Fig. 4 Inﬂuence of PLLA, PLLA-collagen blend and BMP-2
containing PLLA-collagen nanoﬁbers on growth and proliferation
of hMSC cultured under growth and osteoinductive conditions. Time
course of cell densities cultured under growth (a) and osteoinductive
(b) conditions. Immunoﬂuorescence microphotographs of
proliferation as determined by Ki67 staining of hMSC cultured under
osteoinductive conditions on cover PLLA nanoﬁbers (c), PLLA-
collagen blend nanoﬁbers (d) and BMP-2 enwoved PLLA-collagen
blend nanoﬁbers (e). Gene expression of CCND after 4 days of cell
culture as compared to PLLA (f)
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on the differentiation and matrix formation
of hMSC
To examine the inﬂuence of incorporation of BMP-2 into
PLLA-collagen type I on hMSC differentiation into osteo-
blasts we compared the gene expression of alkaline phos-
phatase, collagen type-I and osteocalcin of cells, grown on
PLLA-collagen type I blend nanoﬁbers with or without
BMP-2. Although there was a broad inter-assay variability
(mainlyresponsibleforthelackofsigniﬁcance)thepresence
ofBMP-2resultedinanincreaseofalkalinephosphataseand
osteocalcin (Fig. 5a, b). The reason why osteocalcin and
alkaline phosphatase expression was increased in the early
stageanddecreasedduringthetimecourseisduetotheddCT
method usedtocompare expressionbetweenthe scaffolds at
eachtimepointandnotinatimedependentmanor.Herevon
Kossa as well as alizarin staining gave evidence that
osteogenesis was more dominant when cells were cultured
under osteoinductive conditions. Furthermore when BMP
was incorporated this effect seems to be enhanced (Fig. 5c).
This was accompanied by a signiﬁcant increase in the
gene expression of collagen type I (Fig. 6a) when cells
were cultured on BMP-2 containing nanoﬁber scaffolds as
compared to PLLA-collagen nanoﬁbers alone. This effect
was independent from culture conditions and resulted in an
enhanced deposition of the corresponding proteins in the
nanoﬁber scaffolds over a period of 22 days as demon-
strated by immunoﬂuorescence (Fig. 6b, c, d, e).
3.5 Inﬂuence of nanoﬁber composition signal
transduction
Because collagen blended PLLA nanoﬁbers [19] as well as
BMP-2 containing PLLA nanoﬁbers [16] enhance the dif-
ferentiation of mesenchymal stem cells towards osteoblasts
Fig. 5 Inﬂuence of BMP-2 containing PLLA-collagen blend nanof-
ibers on differentiation of hMSC towards osteoblasts cultured under
growth and osteoinductive conditions. Time course of alkaline
phosphatase (a) and osteocalcin (b) gene expression of hMSC
cultured under growth and osteoinductive conditions on BMP-2
containing PLLA-collagen blend nanoﬁbers compared to PLLA-
collagen blend nanoﬁbers without BMP. c Alizarin (red) and von
Kossa staining (Black) of hMSC cultured under growth and osteo-
inductive conditions on different nanoﬁber scaffolds (Color ﬁgure
online)
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involved in BMP signals in osteoblastic MC3T3-E1 cells
[39] we next analyzed the occurrence of FAK and Samd5
(which are key regulator molecules in the corresponding
pathways) using real time PCR and ﬂuorescence micros-
copy. As compared to PLLA nanoﬁbers alone, the PLLA
collagen type I nanoﬁbers showed an increased expression
gene of the FAK gene (Fig. 7) which resulted in an increase
ofFAKwithinthecells.ThiseffectwasboostedwhenBMP-
2wasincorporatedintothePLLAcollagentypeInanoﬁbers.
Similar ﬁndings were made with respect to Smad5 (Fig. 8),
although the elicited effects by BMP-2 were two times
higher as compared to FAK gene expression.
4 Discussion
Tissue-engineering scaffolds should be analogous to native
ECM in terms of both chemical composition and physical
structure. Polymeric nanoﬁber matrix, with its nanoscaled
nonwoven ﬁbrous structure is a candidate for ECM-
mimetic material [48]. Besides the structural effects (elic-
ited by the nanoﬁbers) signals mediated by growth factors
and/or collagen sequences like RGD-integrin system are
important to develop artiﬁcial tissue. In case of bone
regeneration, members of the TGF-ß superfamily, the bone
morphogenetic proteins are necessary [28–31]. We dem-
onstrated earlier that the incorporation of BMP-2 into
PLLA nanoﬁber scaffolds by electrospinning is useful to
enhance the osteoblastic differentiation of hMSC as
determined by an increased gene expression of genes
associated with the osteoblast [16]. Furthermore it was
shown, that BMP-2 induces the formation of avb-integrins
on osteoblasts [35, 36]. These—in interaction with the
ECM—inﬂuence the BMP-2 function [36]. Beyond that,
Fig. 6 Inﬂuence of PLLA-collagen blend nanoﬁbers and BMP-2
containing PLLA-collagen blend nanoﬁbers on collagen type-I gene
expression and matrix deposition of hMSC cultured under growth and
osteoinductive conditions. Time course of gene expression of hMSC
cultured under growth and osteoinductive conditions (a). Immuno-
ﬂuorescence microphotographs of COL-I (red) deposition after
22 days of culture on PLLA-collagen blend nanoﬁbers (b) BMP-2
containing PLLA-collagen blend nanoﬁbers under growth conditions
(c) or osteoinductive conditions (d, e)
Fig. 7 Inﬂuence of PLLA-collagen blend nanoﬁbers and BMP-2
containing PLLA-collagen blend nanoﬁbers on FAK gene expression
and immunoﬂuorescence detection of FAK in hMSC cultured under
growth and osteoinductive conditions
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to induce osteogenic differentiation of hMSC’s, even in the
absence of exogenous stimuli [20, 21]. Indeed, this prop-
erty is carried to collagen nanoﬁber scaffolds [18, 49]a s
well as nanoﬁber scaffolds form other polymers, blended
with collagen [19, 50].
Within this paper we analyzed whether the combination
of both stimuli (BMP-2 and collagen) have a cooperative
effect when incorporated into PLLA nanoﬁbers.
With respect to adhesion, the BMP incorporation into
PLLA-collagen type I nanoﬁbers resulted in an increased
adhesion of hMSC on the nanoﬁbers. Although we cannot
exclude that the differences in pore size or ﬁber diameter
were involved in this phenomenon, we speculate, that
upregulation of integrins by BMP-2 [35, 36] could be
responsible for this effect. This speculation is supported by
the ﬁnding that cells cultured on this ﬁber type possess
higher gene expression levels as well as protein levels of
focal adhesion kinase, a key regulator of the integrin sig-
naling pathway. However additional studies are necessary
to support this speculation.
As reported earlier, the collagen nanoﬁber scaffold
increased cell densities [19] as well as proliferation.
The additional incorporation of BMP-2 resulted in a
reduced proliferation and lower cell densities. This can be
explained by the osteoinductive stimulus elicited by BMP-
2. In fact we found an increased gene expression of alka-
line phosphatase and osteocalcin, marker of osteoblast
differentiation. Furthermore this speculation is supported
by an upregulation of Smad5 which is involved in
the BMP-2 signal transduction pathway. In addition, this
effect was enhanced when osteoinductive conditions were
applied. The latter ﬁnding is in accordance with coopera-
tive effects between dexamethason and BMP-2 on hMSC
differentiation [51]. Taken together this indicates that
BMP-2 and not the altered ﬁber size is responsible for the
biological effects on hMSC. Therefore our study indicates
that the nanoﬁber scaffolds can be used to combine the
activation of different signal transduction pathways.
This facilitates the use of cooperative effects—at least in
the differentiation of hMSC towards osteoblasts.
Whether this is sufﬁcient for a bone replacement
material, depends although on physical prosperities of the
scaffold. The design of scaffolds for bone tissue engi-
neering is based on the physical properties of bone tissue
such as mechanical strength, pore size, porosity, hardness,
overall 3D architecture and—when used as a drug carrier
system—the presentation of the growth factor. Although
PLLA is known to possess poor protein release properties
[52, 53], during electro-spinning process hydrophilic
compounds were accumulated on the ﬁber surface [54].
The large surface and the porous structure of PLLA
nanoﬁbers, might facilitate contact to the BMP-2 receptor
of the growing cell and elicit differentiation [16]. In case
blend nanoﬁbers similar behavior can be expected. The
latter showed that the growth factor was detectable by
ﬂuorescence microscopy over a period of 14 days.
Although the blend ﬁbers formed a gel-like structure over
time, which was observed earlier in unﬁxed collagen
blended nanoﬁbers [19], this effect had no impact on the
release kinetics of the incorporated BMP-2. This might be
explained by the collagen binding sequence, presented in
BMP-2 [55, 56], retarding the growth factor without
detectable effect on the BMP-bioavailability. Maybe this
form of BMP-2 presentation is similar to the extra cellular
matrix, facilitating the BMP-2 contact to its receptors.
More problematic might be the pore size of the nano-
ﬁber scaffolds. For bone tissue engineering, scaffolds with
a pore size in the range of 100–350 lm are preferred for
better cell/tissue in-growth and hence enhanced bone
regeneration [57, 58]. Here the PLLA-collagen type I as
well as the BMP-2 enwoved PLLA-collagen I nanoﬁber
scaffolds show some disadvantages concerning their pore
size. Whether this might be compensated by the formation
of the gel like structure, or the degradation of collagen after
implantation has to be analyzed in vivo.
Fig. 8 Inﬂuence of PLLA-collagen blend nanoﬁbers and BMP-2
containing PLLA-collagen blend nanoﬁbers on Smad5 gene expres-
sion and immunoﬂuorescence detection of smad5 in hMSC cultured
under growth and osteoinductive conditions
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1235 Conclusion
It has been shown earlier that PLLA nanoﬁber scaffolds
can be functionalized by either growth factors or compo-
nents from the ECM. Here we demonstrated that these
different strategies can be combined in order to enhance the
osteoblast differentiation of hMSC. By doing this, different
signal transduction pathways seemed to be up regulated.
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